Product Name

  • Name

    1-Hydroxyethylethoxypiperazine

  • EINECS 1533716-785-6
  • CAS No. 13349-82-1
  • Article Data12
  • CAS DataBase
  • Density 1.077 g/cm3
  • Solubility
  • Melting Point
  • Formula C8H18N2O2
  • Boiling Point 267.139 °C at 760 mmHg
  • Molecular Weight 174.243
  • Flash Point 115.362 °C
  • Transport Information
  • Appearance yellow-brown oil
  • Safety 26-37/39
  • Risk Codes 36/37/38
  • Molecular Structure Molecular Structure of 13349-82-1 (1-Hydroxyethylethoxypiperazine)
  • Hazard Symbols IrritantXi
  • Synonyms 1-[2-(2-Hydroxyethoxy)ethyl]piperazine;1-[2-[(2-Hydroxyethyl)oxy]ethyl]piperazine;2-[2-(1-Piperazinyl)ethoxy]ethanol;N-Hydroxyethoxyethylpiperazine;3-(Piperazin-1-yloxy)butan-2-ol;1-(2-(2-Hydroxyethoxy)Ethyl)Piperazine);
  • PSA 44.73000
  • LogP -0.83280

Synthetic route

piperazine
110-85-0

piperazine

2-(2-Chloroethoxy)ethanol
628-89-7

2-(2-Chloroethoxy)ethanol

1-[2-(2-hydroxyethoxy)ethyl]piperazine
13349-82-1

1-[2-(2-hydroxyethoxy)ethyl]piperazine

Conditions
ConditionsYield
With piperazine dihydrochloride In ethanol for 10h; Reflux; Large scale;95.1%
at 120 - 140℃; for 1h;70%
tert-butyl 4-(2-(2-hydroxyethoxy)ethyl)piperazine-1-carboxylate
166388-52-9

tert-butyl 4-(2-(2-hydroxyethoxy)ethyl)piperazine-1-carboxylate

1-[2-(2-hydroxyethoxy)ethyl]piperazine
13349-82-1

1-[2-(2-hydroxyethoxy)ethyl]piperazine

Conditions
ConditionsYield
With trifluoroacetic acid In dichloromethane at 20℃; for 2h;95%
With trifluoroacetic acid In dichloromethane at 20℃; for 1h;80%
C17H34N4O4S

C17H34N4O4S

1-[2-(2-hydroxyethoxy)ethyl]piperazine
13349-82-1

1-[2-(2-hydroxyethoxy)ethyl]piperazine

Conditions
ConditionsYield
With dipotassium peroxodisulfate at 30 - 60℃; for 6h; Reagent/catalyst;80.5%
4-ethoxycarbonylpiperazine
120-43-4

4-ethoxycarbonylpiperazine

2-(2-Chloroethoxy)ethanol
628-89-7

2-(2-Chloroethoxy)ethanol

1-[2-(2-hydroxyethoxy)ethyl]piperazine
13349-82-1

1-[2-(2-hydroxyethoxy)ethyl]piperazine

Conditions
ConditionsYield
With potassium hydroxide; ethanol
Quetiapine
111974-69-7

Quetiapine

A

1-[2-(2-hydroxyethoxy)ethyl]piperazine
13349-82-1

1-[2-(2-hydroxyethoxy)ethyl]piperazine

B

2-[2-(4,5-dihydro-1H-imidazol-1-yl)ethoxy]ethanol

2-[2-(4,5-dihydro-1H-imidazol-1-yl)ethoxy]ethanol

C

2-[2-(1-oxidopiperazin-1-yl)ethoxy]ethanol
1216996-50-7

2-[2-(1-oxidopiperazin-1-yl)ethoxy]ethanol

D

dibenzo[b,f]-1,4-thiazepine
257-15-8

dibenzo[b,f]-1,4-thiazepine

E

Quetiapine sulfoxide

Quetiapine sulfoxide

Conditions
ConditionsYield
In methanol at 25℃; for 6h; Kinetics; UV-irradiation;
2,2'-iminobis[ethanol]
111-42-2

2,2'-iminobis[ethanol]

2-(2-Aminoethoxy)ethanol
929-06-6

2-(2-Aminoethoxy)ethanol

1-[2-(2-hydroxyethoxy)ethyl]piperazine
13349-82-1

1-[2-(2-hydroxyethoxy)ethyl]piperazine

Conditions
ConditionsYield
With hydrogen at 180℃; under 150015 Torr; for 15h;
With hydrogen at 180℃; under 750.075 - 150015 Torr; Time;
With hydrogen at 180℃; under 150015 Torr; for 15h;
1-[2-(2-hydroxyethoxy)ethyl]piperazine
13349-82-1

1-[2-(2-hydroxyethoxy)ethyl]piperazine

(2′Z-3′E)-6-bromoindirubin-3′-[O-(2-bromoethyl)oxime]
1067884-35-8

(2′Z-3′E)-6-bromoindirubin-3′-[O-(2-bromoethyl)oxime]

(2'Z-3'E)-6-bromoindirubin-3'-[O-(2-{4-[2-(2-hydroxyethoxy)-ethyl]piperazin-1-yl}ethyl)oxime]
1067884-49-4

(2'Z-3'E)-6-bromoindirubin-3'-[O-(2-{4-[2-(2-hydroxyethoxy)-ethyl]piperazin-1-yl}ethyl)oxime]

Conditions
ConditionsYield
In N,N-dimethyl-formamide at 50℃;100%
1-[2-(2-hydroxyethoxy)ethyl]piperazine
13349-82-1

1-[2-(2-hydroxyethoxy)ethyl]piperazine

acrylonitrile
107-13-1

acrylonitrile

3-{4-[2-(2-hydroxy-ethoxy)ethyl]-piperazin-1-yl}-propionitrile
1278584-73-8

3-{4-[2-(2-hydroxy-ethoxy)ethyl]-piperazin-1-yl}-propionitrile

Conditions
ConditionsYield
at 20℃; for 72h; Michael addition;100%
1-[2-(2-hydroxyethoxy)ethyl]piperazine
13349-82-1

1-[2-(2-hydroxyethoxy)ethyl]piperazine

11-chloro-dibenzo[b,f][1,4]thiazepine
13745-86-3

11-chloro-dibenzo[b,f][1,4]thiazepine

Quetiapine
111974-69-7

Quetiapine

Conditions
ConditionsYield
In toluene at 105 - 107℃;99%
In toluene at 110 - 120℃; for 8h; Product distribution / selectivity;98%
In toluene Reflux;92%
1-[2-(2-hydroxyethoxy)ethyl]piperazine
13349-82-1

1-[2-(2-hydroxyethoxy)ethyl]piperazine

(S)-N-[(3-bromo-propyl)(oxido)phenyl-λ4-sulfanylidene]-5-({3-[(3-methyl-2-furoyl)amino]phenyl}ethynyl)nicotinamide
1027727-66-7

(S)-N-[(3-bromo-propyl)(oxido)phenyl-λ4-sulfanylidene]-5-({3-[(3-methyl-2-furoyl)amino]phenyl}ethynyl)nicotinamide

(S)-N-[(3-{4-[2-(2-hydroxyethoxy)ethyl]piperazin-1-yl}propyl)(oxido)phenyl-λ4-sulfanylidene]-5-({3-[(3-methyl-2-furoyl)amino]phenyl}ethynyl)nicotinamide
1027727-68-9

(S)-N-[(3-{4-[2-(2-hydroxyethoxy)ethyl]piperazin-1-yl}propyl)(oxido)phenyl-λ4-sulfanylidene]-5-({3-[(3-methyl-2-furoyl)amino]phenyl}ethynyl)nicotinamide

Conditions
ConditionsYield
In N,N-dimethyl-formamide at 80℃; for 0.5h;96%
1-[2-(2-hydroxyethoxy)ethyl]piperazine
13349-82-1

1-[2-(2-hydroxyethoxy)ethyl]piperazine

11-chlorodibenzo[b,f][1,4]thiazepin-11-one

11-chlorodibenzo[b,f][1,4]thiazepin-11-one

(2E)-but-2-enedioic acid
110-17-8

(2E)-but-2-enedioic acid

11-[4-[2-(2-hydroxyethoxy)ethyl]-1-piperazinyl]dibenzo[b,f][1,4]thiazepine hemifumarate salt

11-[4-[2-(2-hydroxyethoxy)ethyl]-1-piperazinyl]dibenzo[b,f][1,4]thiazepine hemifumarate salt

Conditions
ConditionsYield
Stage #1: 1-[2-(2-hydroxyethoxy)ethyl]piperazine; 11-chlorodibenzo[b,f][1,4]thiazepin-11-one With potassium carbonate In toluene for 5h; Reflux; Large scale;
Stage #2: (2E)-but-2-enedioic acid In ethanol for 1.5h; Reflux; Large scale;
95.3%
2,2-dimethylthiirane
3772-13-2

2,2-dimethylthiirane

1-[2-(2-hydroxyethoxy)ethyl]piperazine
13349-82-1

1-[2-(2-hydroxyethoxy)ethyl]piperazine

2-(2-{4-[2-Methyl-2-sulfanylpropyl]piperazinyl}ethoxy)ethan-1-ol

2-(2-{4-[2-Methyl-2-sulfanylpropyl]piperazinyl}ethoxy)ethan-1-ol

Conditions
ConditionsYield
at 80℃; for 4h;93%
1-[2-(2-hydroxyethoxy)ethyl]piperazine
13349-82-1

1-[2-(2-hydroxyethoxy)ethyl]piperazine

di-tert-butyl dicarbonate
24424-99-5

di-tert-butyl dicarbonate

tert-butyl 4-(2-(2-hydroxyethoxy)ethyl)piperazine-1-carboxylate
166388-52-9

tert-butyl 4-(2-(2-hydroxyethoxy)ethyl)piperazine-1-carboxylate

Conditions
ConditionsYield
In dichloromethane at 0 - 20℃; for 12h;92%
In dichloromethane at 0 - 20℃;92%
With sodium hydrogencarbonate In dichloromethane at 0 - 20℃; for 12h;92%
In dichloromethane at 20℃;
With triethylamine In dichloromethane at 20℃; for 12h;
1-[2-(2-hydroxyethoxy)ethyl]piperazine
13349-82-1

1-[2-(2-hydroxyethoxy)ethyl]piperazine

2-(4-chloro-3-nitrophenyl)-3-hydroxyquinoline-4(1H)-one
1011306-89-0

2-(4-chloro-3-nitrophenyl)-3-hydroxyquinoline-4(1H)-one

3-hydroxy-2-(4-{4-[2-(2-hydroxyethoxy)ethyl]piperazin-1-yl}-3-nitrophenyl)quinolin-4(1H)-one

3-hydroxy-2-(4-{4-[2-(2-hydroxyethoxy)ethyl]piperazin-1-yl}-3-nitrophenyl)quinolin-4(1H)-one

Conditions
ConditionsYield
With 1-methyl-pyrrolidin-2-one at 110℃; for 2h;91%
1-[2-(2-hydroxyethoxy)ethyl]piperazine
13349-82-1

1-[2-(2-hydroxyethoxy)ethyl]piperazine

2-(2,6-dioxopiperidin-3-yl)-5-fluoro-2,3-dihydro-1H-isoindole-1,3-dione
835616-61-0

2-(2,6-dioxopiperidin-3-yl)-5-fluoro-2,3-dihydro-1H-isoindole-1,3-dione

2-(2,6-dioxopiperidin-3-yl)-5-(4-(2-(2-hydroxyethoxy)ethyl)piperazin-1-yl)isoindoline-1,3-dione

2-(2,6-dioxopiperidin-3-yl)-5-(4-(2-(2-hydroxyethoxy)ethyl)piperazin-1-yl)isoindoline-1,3-dione

Conditions
ConditionsYield
With N-ethyl-N,N-diisopropylamine In 1-methyl-pyrrolidin-2-one at 90℃; for 3h;89.8%
1-[2-(2-hydroxyethoxy)ethyl]piperazine
13349-82-1

1-[2-(2-hydroxyethoxy)ethyl]piperazine

2‑(2‑nitrophenylsulfanyl)benzoic acid
19806-43-0

2‑(2‑nitrophenylsulfanyl)benzoic acid

2-nitro-2'-[4-[2-(2-hydroxyethoxy)ethyl]-piperazinylcarbonyl]diphenylsulfide
849790-30-3

2-nitro-2'-[4-[2-(2-hydroxyethoxy)ethyl]-piperazinylcarbonyl]diphenylsulfide

Conditions
ConditionsYield
Stage #1: 2‑(2‑nitrophenylsulfanyl)benzoic acid With thionyl chloride In dichloromethane at 40℃;
Stage #2: 1-[2-(2-hydroxyethoxy)ethyl]piperazine With triethylamine In dichloromethane at 0 - 5℃;
89.7%
Stage #1: 2‑(2‑nitrophenylsulfanyl)benzoic acid With 4-methyl-morpholine; triethylamine In dichloromethane at 20℃; for 0.25h;
Stage #2: 1-[2-(2-hydroxyethoxy)ethyl]piperazine With pivaloyl chloride In dichloromethane
1-[2-(2-hydroxyethoxy)ethyl]piperazine
13349-82-1

1-[2-(2-hydroxyethoxy)ethyl]piperazine

carbon disulfide
75-15-0

carbon disulfide

t-butyl bromide
507-19-7

t-butyl bromide

4-[2-(2-hydroxy-ethoxy)-ethyl]-piperazine-1-carbodithioic acid tert-butyl ester

4-[2-(2-hydroxy-ethoxy)-ethyl]-piperazine-1-carbodithioic acid tert-butyl ester

Conditions
ConditionsYield
With tetra-(n-butyl)ammonium iodide; caesium carbonate In N,N-dimethyl-formamide at 0 - 20℃; for 0.5h;89%
1-[2-(2-hydroxyethoxy)ethyl]piperazine
13349-82-1

1-[2-(2-hydroxyethoxy)ethyl]piperazine

(3E)-6-fluoro-3-[4-(2-fluoropyridin-4-yl)-5,5-dimethylfuran-2(5H)-ylidene]-1,3-dihydro-2H-indol-2-one

(3E)-6-fluoro-3-[4-(2-fluoropyridin-4-yl)-5,5-dimethylfuran-2(5H)-ylidene]-1,3-dihydro-2H-indol-2-one

(3E)-6-fluoro-3-[4-(2-{4-[2-(2-hydroxyethoxy)ethyl]piperazin-1-yl}pyridin-4-yl)-5,5-dimethylfuran-2(5H)-ylidene]-1,3-dihydro-2H-indol-2-one

(3E)-6-fluoro-3-[4-(2-{4-[2-(2-hydroxyethoxy)ethyl]piperazin-1-yl}pyridin-4-yl)-5,5-dimethylfuran-2(5H)-ylidene]-1,3-dihydro-2H-indol-2-one

Conditions
ConditionsYield
In dimethyl sulfoxide at 105℃; for 6h;89%
1-[2-(2-hydroxyethoxy)ethyl]piperazine
13349-82-1

1-[2-(2-hydroxyethoxy)ethyl]piperazine

6,7-difluoro-3-hydroxy-2-phenylquinolin-4(1H)-one

6,7-difluoro-3-hydroxy-2-phenylquinolin-4(1H)-one

7-fluoro-3-hydroxy-6-(4-(2-(2-hydroxyethoxy)ethyl)piperazin-1-yl)2-phenylquinolin-4(1H)-one

7-fluoro-3-hydroxy-6-(4-(2-(2-hydroxyethoxy)ethyl)piperazin-1-yl)2-phenylquinolin-4(1H)-one

Conditions
ConditionsYield
In 1-methyl-pyrrolidin-2-one for 3h; Reflux;89%
1-[2-(2-hydroxyethoxy)ethyl]piperazine
13349-82-1

1-[2-(2-hydroxyethoxy)ethyl]piperazine

2-(2-(4-(pyrazin-2-yl)piperazin-1-yl)ethoxy)ethan-1-ol

2-(2-(4-(pyrazin-2-yl)piperazin-1-yl)ethoxy)ethan-1-ol

Conditions
ConditionsYield
With iodine; sodium acetate In acetonitrile at 70℃;88%
1-[2-(2-hydroxyethoxy)ethyl]piperazine
13349-82-1

1-[2-(2-hydroxyethoxy)ethyl]piperazine

13-cyclohexyl-10-[[((dimethylamino)sulfonyl)amino]carbonyl]-3-methoxy-7H-indolo[2,1a][2]benzazepine-6-carboxylic acid
902148-42-9

13-cyclohexyl-10-[[((dimethylamino)sulfonyl)amino]carbonyl]-3-methoxy-7H-indolo[2,1a][2]benzazepine-6-carboxylic acid

13-cyclohexyl-N-[(dimethylamino)sulfonyl]-6-[[4-[2-(2-hydroxyethoxy)ethyl]-1-piperazinyl]carbonyl]-3-methoxy-7H-indolo[2,1-a][2]benzazepine-10-carboxamide

13-cyclohexyl-N-[(dimethylamino)sulfonyl]-6-[[4-[2-(2-hydroxyethoxy)ethyl]-1-piperazinyl]carbonyl]-3-methoxy-7H-indolo[2,1-a][2]benzazepine-10-carboxamide

Conditions
ConditionsYield
With triethylamine; HATU In N,N-dimethyl-formamide at 20℃; for 1h;87%
1-[2-(2-hydroxyethoxy)ethyl]piperazine
13349-82-1

1-[2-(2-hydroxyethoxy)ethyl]piperazine

C66H84Cl8N34

C66H84Cl8N34

C98H152Cl4N42O8

C98H152Cl4N42O8

Conditions
ConditionsYield
With N-ethyl-N,N-diisopropylamine In tetrahydrofuran; dichloromethane at -20 - 20℃;85%
1-[2-(2-hydroxyethoxy)ethyl]piperazine
13349-82-1

1-[2-(2-hydroxyethoxy)ethyl]piperazine

N-hydroxyethyl-4-bromine-1,8-naphthalimide
52559-37-2

N-hydroxyethyl-4-bromine-1,8-naphthalimide

N-(2-hydroxyethyl)-4-(4-[2-(2-hydroxyethoxy)ethyl]-piperazine-1-yl)-1,8-naphthalimide

N-(2-hydroxyethyl)-4-(4-[2-(2-hydroxyethoxy)ethyl]-piperazine-1-yl)-1,8-naphthalimide

Conditions
ConditionsYield
In 2-methoxy-ethanol at 130℃; for 1h; Microwave irradiation; Inert atmosphere;85%
1-[2-(2-hydroxyethoxy)ethyl]piperazine
13349-82-1

1-[2-(2-hydroxyethoxy)ethyl]piperazine

6-bromo-2-(2-methoxyethyl)-1H-benzo[de]isoquinoline-1,3(2H)-dione
651768-37-5

6-bromo-2-(2-methoxyethyl)-1H-benzo[de]isoquinoline-1,3(2H)-dione

N-(2-methoxyethyl)-4-(4-[2-(2-Hydroxyethoxy)ethyl]-piperazine-1-yl)-1,8-naphthalimide

N-(2-methoxyethyl)-4-(4-[2-(2-Hydroxyethoxy)ethyl]-piperazine-1-yl)-1,8-naphthalimide

Conditions
ConditionsYield
In 2-methoxy-ethanol at 130℃; for 1h; Microwave irradiation; Inert atmosphere;85%
2-iodopyridine
5029-67-4

2-iodopyridine

1-[2-(2-hydroxyethoxy)ethyl]piperazine
13349-82-1

1-[2-(2-hydroxyethoxy)ethyl]piperazine

A

C13H21O2N3

C13H21O2N3

B

1-(2-(2-(pyridin-2-yloxy)ethoxy)ethyl)piperazine

1-(2-(2-(pyridin-2-yloxy)ethoxy)ethyl)piperazine

Conditions
ConditionsYield
With 2-(2-methyl-1-oxopropyl)cyclohexanone; caesium carbonate; copper(l) iodide In N,N-dimethyl-formamide at 20℃; for 16h;A 83%
B n/a
1-[2-(2-hydroxyethoxy)ethyl]piperazine
13349-82-1

1-[2-(2-hydroxyethoxy)ethyl]piperazine

dibenzo[b,f][1,4]thiazepin-11-ylamine hydrochloride
1176987-11-3

dibenzo[b,f][1,4]thiazepin-11-ylamine hydrochloride

(2E)-but-2-enedioic acid
110-17-8

(2E)-but-2-enedioic acid

quetiapine fumarate
111974-72-2

quetiapine fumarate

Conditions
ConditionsYield
Stage #1: 1-[2-(2-hydroxyethoxy)ethyl]piperazine; dibenzo[b,f][1,4]thiazepin-11-ylamine hydrochloride at 172 - 176℃; for 5h;
Stage #2: In water at 20 - 65℃;
Stage #3: (2E)-but-2-enedioic acid In isopropyl alcohol at 4 - 20℃; Product distribution / selectivity;
83%
Stage #1: 1-[2-(2-hydroxyethoxy)ethyl]piperazine; dibenzo[b,f][1,4]thiazepin-11-ylamine hydrochloride at 173 - 175℃; for 5h;
Stage #2: With potassium carbonate In water at 20 - 75℃;
Stage #3: (2E)-but-2-enedioic acid In isopropyl alcohol at 4 - 20℃; Product distribution / selectivity;
79%
2-iodopyridine
5029-67-4

2-iodopyridine

1-[2-(2-hydroxyethoxy)ethyl]piperazine
13349-82-1

1-[2-(2-hydroxyethoxy)ethyl]piperazine

1-(2-(2-(pyridin-2-yloxy)ethoxy)ethyl)piperazine

1-(2-(2-(pyridin-2-yloxy)ethoxy)ethyl)piperazine

Conditions
ConditionsYield
With 3,4,7,8-Tetramethyl-o-phenanthrolin; 3 A molecular sieve; caesium carbonate; copper(l) iodide at 90℃; for 20h;82%
1-[2-(2-hydroxyethoxy)ethyl]piperazine
13349-82-1

1-[2-(2-hydroxyethoxy)ethyl]piperazine

5-chloro-2-bromomethyl-9H-xanthen-9-one
76967-95-8

5-chloro-2-bromomethyl-9H-xanthen-9-one

5-chloro-2-((4-(2-(2-hydroxyethoxy)ethyl)piperazin-1-yl)methyl)-9H-xanthen-9-one dihydrochloride

5-chloro-2-((4-(2-(2-hydroxyethoxy)ethyl)piperazin-1-yl)methyl)-9H-xanthen-9-one dihydrochloride

Conditions
ConditionsYield
Stage #1: 1-[2-(2-hydroxyethoxy)ethyl]piperazine; 5-chloro-2-bromomethyl-9H-xanthen-9-one With potassium carbonate In toluene at 110℃; for 72h;
Stage #2: With hydrogenchloride In ethanol; water
82%
1-[2-(2-hydroxyethoxy)ethyl]piperazine
13349-82-1

1-[2-(2-hydroxyethoxy)ethyl]piperazine

benzyl(bromo)zinc
62673-31-8

benzyl(bromo)zinc

benzaldehyde
100-52-7

benzaldehyde

2-(2-(4-(1,2-diphenylethyl)piperazin-1-yl)ethoxy)ethanol

2-(2-(4-(1,2-diphenylethyl)piperazin-1-yl)ethoxy)ethanol

Conditions
ConditionsYield
In acetonitrile at 20℃; for 4h;80%
1-[2-(2-hydroxyethoxy)ethyl]piperazine
13349-82-1

1-[2-(2-hydroxyethoxy)ethyl]piperazine

1-(7-chloroquinolin-4-yl)-3-(3-nitrophenyl)thiourea

1-(7-chloroquinolin-4-yl)-3-(3-nitrophenyl)thiourea

1-(7-(4-(2-(2-hydroxyethoxy)ethyl)piperazin-1-yl)quinolin-4-yl)-3-(3-nitrophenyl)thiourea

1-(7-(4-(2-(2-hydroxyethoxy)ethyl)piperazin-1-yl)quinolin-4-yl)-3-(3-nitrophenyl)thiourea

Conditions
ConditionsYield
With copper In water at 100℃; Sealed tube;79%
1-[2-(2-hydroxyethoxy)ethyl]piperazine
13349-82-1

1-[2-(2-hydroxyethoxy)ethyl]piperazine

N-[(3-bromopropyl)(methyl)oxido-λ4-sulfanylidene]-5-({3-[(3-methyl-2-furoyl)amino]phenyl}ethynyl)nicotinamide

N-[(3-bromopropyl)(methyl)oxido-λ4-sulfanylidene]-5-({3-[(3-methyl-2-furoyl)amino]phenyl}ethynyl)nicotinamide

N-[(3-{4-[2-(2-hydroxyethoxyl)ethyl]piperazin-1-yl}propyl)(methyl)oxido-λ4-sulfanylidene]-5-({3-[(3-methyl-2-furoyl)amino]phenyl}ethynyl)nicotinamide

N-[(3-{4-[2-(2-hydroxyethoxyl)ethyl]piperazin-1-yl}propyl)(methyl)oxido-λ4-sulfanylidene]-5-({3-[(3-methyl-2-furoyl)amino]phenyl}ethynyl)nicotinamide

Conditions
ConditionsYield
In N,N-dimethyl-formamide at 60℃; for 0.666667h;78%
1-[2-(2-hydroxyethoxy)ethyl]piperazine
13349-82-1

1-[2-(2-hydroxyethoxy)ethyl]piperazine

5-bromo-2-furancarboxaldehyde
1899-24-7

5-bromo-2-furancarboxaldehyde

N-phenyl-maleimide
941-69-5

N-phenyl-maleimide

A

C18H25N3O4
355003-04-2

C18H25N3O4

B

C23H25N3O5
1017832-31-3

C23H25N3O5

Conditions
ConditionsYield
Stage #1: 1-[2-(2-hydroxyethoxy)ethyl]piperazine; 5-bromo-2-furancarboxaldehyde With triethylamine In 1,4-dioxane; water for 4h; Heating;
Stage #2: N-phenyl-maleimide With magnesium sulfate In 1,4-dioxane; water for 18h; Diels-Alder reaction; Heating; Further stages.;
A n/a
B 77%
1-[2-(2-hydroxyethoxy)ethyl]piperazine
13349-82-1

1-[2-(2-hydroxyethoxy)ethyl]piperazine

bromoacetic acid tert-butyl ester
5292-43-3

bromoacetic acid tert-butyl ester

tert-butyl 2-(4-(2-(2-hydroxyethoxy)ethyl)piperazin-1-yl)acetate

tert-butyl 2-(4-(2-(2-hydroxyethoxy)ethyl)piperazin-1-yl)acetate

Conditions
ConditionsYield
With triethanolamine In tetrahydrofuran; N,N-dimethyl-formamide at 50℃; for 16h;77%

1-Hydroxyethylethoxypiperazine Specification

1-Hydroxyethylethoxypiperazine, with the CAS number of 13349-82-1, can be called 2-butanol, 3-(1-piperazinyloxy)-; 3-(Piperazin-1-yloxy)butan-2-ol. It belongs to the categories of  Piperidine; Piperidines, Piperidones, Piperazines; Piperazine derivates; API intermediates; (intermediate of quadipine); (intermediate of quetiapine fumarate); Miscellaneous Reagents; Intermediates of Quetiapine. It is a yellow-brown oil,can be used as quetiapine intermediate.

Physical properties about 1-Hydroxyethylethoxypiperazine are: (1)ACD/LogP: 0.183; (2)ACD/LogD (pH 5.5): -2.62; (3)ACD/LogD (pH 7.4): -1.04; (4)ACD/BCF (pH 5.5): 1.00; (5)ACD/BCF (pH 7.4): 1.00; (6)ACD/KOC (pH 5.5): 1.00; (7)ACD/KOC (pH 7.4): 1.79; (8)#H bond acceptors: 4; (9)#H bond donors: 2; (10)#Freely Rotating Bonds: 4; (11)Index of Refraction: 1.503; (12)Molar Refractivity: 47.804 cm3; (13)Molar Volume: 161.842 cm3; (14)Polarizability: 18.951 10-24cm3; (15)Surface Tension: 40.6640014648438 dyne/cm; (16)Density: 1.077 g/cm3; (17)Flash Point: 115.362 °C; (18)Enthalpy of Vaporization: 58.658 kJ/mol; (19)Boiling Point: 267.139 °C at 760 mmHg; (20)Vapour Pressure: 0.00100000004749745 mmHg at 25°C

When you are using this chemical, please be cautious about it as the following:
1. In case of contact with eyes, rinse immediately with plenty of water and seek medical advice;
2. Wear suitable gloves and eye/face protection;

You can still convert the following datas into molecular structure:
(1)InChI=1S/C8H18N2O2/c11-6-8-12-7-5-10-3-1-9-2-4-10/h9,11H,1-8H2;
(2)InChIKey=FLNQAPQQAZVRDA-UHFFFAOYSA-N;
(3)SmilesN1(CCOCCO)CCNCC1

Post buying leads

About|Contact|Cas|Product Name|Molecular|Country|Encyclopedia

Message|New Cas|MSDS|Service|Advertisement|CAS DataBase|Article Data|Manufacturers | Chemical Catalog

©2008 LookChem.com,License: ICP

NO.:Zhejiang16009103

complaints:service@lookchem.com Desktop View